
Tnine Pharmaceuticals Private Limited
About Tnine Pharmaceuticals Private Limited
Data last updated:
Tnine Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 26 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC344673.
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Basundhara Singh and Kamlesh Chandulal Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3/101 B.Y. Apt Chs Ltd B G Kher Marg Plot 868 Campa Cola Compound Worli, Mumbai, Maharashtra, India – 400018.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.78 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2.99 Lakh (net margin -25.4%) and EBITDA of ₹1.62 Lakh (EBITDA margin 13.7%).
Company details
Contact details
Tnine Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address3/101 B.Y. Apt Chs Ltd B G Kher Marg Plot 868 Campa Cola Compound Worli, Mumbai, Maharashtra, India – 400018
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Tnine Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Tnine Pharmaceuticals Private Limited, buy the company report.
Financials of Tnine Pharmaceuticals Private Limited
FY 2025 filings availableTnine Pharmaceuticals Private Limited reported revenue of ₹11.78 Lakh (up 2617% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.62 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.99 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.7% | ||||
| Net Profit Margin | -25.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tnine Pharmaceuticals Private Limited, buy the company report.
Board of directors of Tnine Pharmaceuticals Private Limited
Tnine Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Basundhara Singh | Director | 26 Aug 2020 | 6 Years 2 Months | Current |
| Kamlesh Chandulal Shah | Director | 26 Aug 2020 | 6 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Tnine Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tnine Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Tnine Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Tnine Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Basundhara Singh was appointed as Director on 26 Aug 2020.
Frequently asked questions
Tnine Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 26 August 2020 (6+ years old) and is registered under CIN U51909MH2020PTC344673.
Tnine Pharmaceuticals has 2 current directors:
- Basundhara Singh - Director
- Kamlesh Chandulal Shah - Director
The latest financial statements of Tnine Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Tnine Pharmaceuticals is U51909MH2020PTC344673. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tnine Pharmaceuticals was incorporated on 26 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Basundhara Singh was appointed as Director on 26 Aug 2020. Kamlesh Chandulal Shah was appointed as Director on 26 Aug 2020.
The registered office of Tnine Pharmaceuticals is at 3101 B.Y. Apt Chs Ltd B G Kher Marg Plot 868 Campa Cola Compound Worli, Mumbai, Maharashtra, India – 400018.
Tnine Pharmaceuticals operates in the trading industry, in the specialty segment.
Tnine Pharmaceuticals can be reached at its registered office: 3101 B.Y. Apt Chs Ltd B G Kher Marg Plot 868 Campa Cola Compound Worli, Mumbai, Maharashtra, India – 400018.
Tnine Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.